Literature DB >> 28545168

Reliability of the triple-timed up-and-go test.

Donald B Sanders1, Jeffrey T Guptill1, Kathy L Aleš2, Lisa D Hobson-Webb1, David P Jacobus2, Riaz Mahmood3, Janice M Massey1, Melissa M Pittman1, Kristi Prather4, Shruti M Raja1, Eric Yow4, Vern C Juel1.   

Abstract

INTRODUCTION: We report the reliability of a new measure, the triple-timed up-and-go (3TUG) test, for assessing clinical function in patients with Lambert-Eaton myasthenia (LEM).
METHODS: Intrarater reproducibility and interrater agreement of the 3TUG test were assessed in 25 control participants, 24 patients with non-LEM neuromuscular disease, and 12 patients with LEM. The coverage probability (CP) method was the primary measure of reproducibility and agreement. The a priori acceptable range was < 20% difference in 3TUG test times and a CP ≥0.90 confirmed agreement.
RESULTS: CP values > 0.90 for intrarater and interrater tests confirmed acceptable reproducibility and agreement for all groups. DISCUSSION: The 3TUG test is a quick, noninvasive, and reproducible measure that is easy to perform, measures clinically important weakness in LEM patients, and requires little training. Additional evaluation in a larger number of LEM patients is in progress to validate the 3TUG test as a clinical measure in LEM. Muscle Nerve 57: 136-139, 2017.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  3,4-diaminopyridine; Lambert-Eaton myasthenia; coverage probability; outcome measures; reliability; timed up-and-go test

Mesh:

Year:  2017        PMID: 28545168      PMCID: PMC5702274          DOI: 10.1002/mus.25700

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting.

Authors:  Huiman X Barnhart; Eric Yow; Anna Lisa Crowley; Melissa A Daubert; Dawn Rabineau; Robert Bigelow; Michael Pencina; Pamela S Douglas
Journal:  Stat Methods Med Res       Date:  2014-05-14       Impact factor: 3.021

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.

Authors:  Teresa M Steffen; Timothy A Hacker; Louise Mollinger
Journal:  Phys Ther       Date:  2002-02

4.  Minimal detectable change of the timed "up & go" test and the dynamic gait index in people with Parkinson disease.

Authors:  Sheau-Ling Huang; Ching-Lin Hsieh; Ruey-Meei Wu; Chun-Hwei Tai; Chin-Hsien Lin; Wen-Shian Lu
Journal:  Phys Ther       Date:  2010-10-14

5.  Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.

Authors:  S Morris; M E Morris; R Iansek
Journal:  Phys Ther       Date:  2001-02

6.  Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women.

Authors:  Heike A Bischoff; Hannes B Stähelin; Andreas U Monsch; Maura D Iversen; Antje Weyh; Margot von Dechend; Regula Akos; Martin Conzelmann; Walter Dick; Robert Theiler
Journal:  Age Ageing       Date:  2003-05       Impact factor: 10.668

7.  Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease.

Authors:  Julie D Ries; John L Echternach; Leah Nof; Michelle Gagnon Blodgett
Journal:  Phys Ther       Date:  2009-04-23
  7 in total
  4 in total

1.  Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy.

Authors:  Vincenzo Montano; Francesco Gruosso; Valerio Carelli; Giacomo Pietro Comi; Massimiliano Filosto; Costanza Lamperti; Tiziana Mongini; Olimpia Musumeci; Serenella Servidei; Paola Tonin; Antonio Toscano; Angela Modenese; Guido Primiano; Maria Lucia Valentino; Sara Bortolani; Silvia Marchet; Megi Meneri; Graziana Tavilla; Gabriele Siciliano; Michelangelo Mancuso
Journal:  Neurol Genet       Date:  2020-10-20

2.  Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.

Authors:  Karoliny Lisandra Teixeira Cruz; Ana Cristina Resende Camargos; Juliana Cardoso; Cyntia Rogean de Jesus Alves de Baptista; Aline Duprat Ramos; Ana Claudia Mattiello-Sverzut; Joshua Burns; Hércules Ribeiro Leite
Journal:  Braz J Phys Ther       Date:  2020-08-07       Impact factor: 3.377

3.  Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery.

Authors:  Xin Shelley Wang; Mona Kamal; Tsun Hsuan Chen; Qiuling Shi; Araceli Garcia-Gonzalez; Maria D Iniesta; Charles S Cleeland; Vijaya Gottumukkala; Larissa A Meyer
Journal:  Gynecol Oncol       Date:  2021-01-31       Impact factor: 5.482

4.  3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.

Authors:  Donald B Sanders; Vern C Juel; Yadollah Harati; A Gordon Smith; Amanda C Peltier; Tessa Marburger; Jau-Shin Lou; Robert M Pascuzzi; David P Richman; Tai Xie; Valentin Demmel; Laura R Jacobus; Kathy L Aleš; David P Jacobus
Journal:  Muscle Nerve       Date:  2018-02-02       Impact factor: 3.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.